Results 1 - 1 of 1
(Click here to explore results)
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. Franck Duclos, Lynn M. Abell, David G. Harden, Kristen Pike, Kimberly Nowak, Gregory A. Locke, Gerald J. Duke, Xiaoqin Liu, Gayani Fernando, Scott A. Shaw, Benjamin P. Vokits, Nicholas R. Wurtz, Andrew Viet, Meriah N. Valente, Sylwia Stachura, Paul Sleph, Javed A. Khan, Ji Gao, Ashok R. Dongre, Lei Zhao, Ruth R. Wexler, David A. Gordon, Ellen K. Kick
, Med. Chem. Commun.
, 2017
, 8
, 2093